Company: HBCYF
Filing Date: 2025-10-28
Form Type: 6-K
Source: 0001089113-25-000056
Chunk: 18

Company: HSBC HOLDINGS PLC
Filing Date: 2025-10-28
Form: 6-K
Chunk 18
---
52.2 |        45.0 |          56.6 |        54.1 |        47.9 |

1 For the nine months ended 30 September 2025, the amounts include a $0.1bn mark-to-market gain on interest rate hedging of the portfolio of retained loans post sale of our retail banking operations in France and a $0.1bn mark-to-market loss on Grupo Financiero Galicia‘s (‘Galicia‘) American Depositary Receipts (‘ADRs‘) received as purchase consideration from the sale of our business in Argentina. For the nine months ended 30 September 2024, the amounts include a $255m gain on the foreign exchange hedging of the proceeds from the sale of our banking business in Canada. 2 For the nine months ended 30 September 2024, a gain of $4.6bn, inclusive of the recycling of $0.6bn in foreign currency translation reserve losses and $0.4bn of other reserves recycling losses but excluding the $255m gain on the foreign exchange hedging (see footnote 1 above), on the sale of our banking business in Canada, and an impairment loss of $1.2bn relating to the sale of our business in Argentina were recognised. 3 For the nine months ended 30 September 2025, the amounts in ‘Other operating (expense)/income’ include a loss of $1.1bn inclusive of reserves recycling as a result of the dilution of our shareholding in BoCom. We have also recognised a $1.0bn impairment loss following an impairment test on the carrying value of the Group’s investment in BoCom in ‘Impairment of interest in associate’. 4 Net operating income before change in expected credit losses and other credit impairment charges, also referred to as revenue. 5 The $0.56 dividend paid during the nine month period ended 30 September 2025 consisted of a fourth interim dividend of $0.36 per ordinary share in respect of the financial year ended 31 December 2024 paid in April 2025, and first and second interim dividends of $0.10 per ordinary share in respect of the financial year ended 31 December 2025 paid in June 2025 and September 2025, respectively.

Income statement results 3Q25 compared with 3Q24 – reported results

| Movement in reported profit compared with3Q24      | Quarter ended |             |               |     |